{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:38:31Z","timestamp":1778629111257,"version":"3.51.4"},"reference-count":68,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute on Drug Abuse","award":["R34DA052178"],"award-info":[{"award-number":["R34DA052178"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: Although Africa has long borne the brunt of the human immunodeficiency virus (HIV) epidemic, until recently, the continent has been considered largely free of illicit drug use and injection drug use in particular. In Uganda, the number of people who use or inject drugs (PWUD and PWID, respectively) has increased, and PWID are a key population at high risk for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection. However, harm reduction practices, including providing clean injection equipment and medication-assisted treatment (MAT), have only recently been piloted in the country. This project aims to integrate buprenorphine into a harm reduction drop-in center (DIC). Methods: The Consolidated Framework for Implementation Research was used to guide our preparations to integrate buprenorphine into existing practices at a harm reduction DIC. We conducted key informant interviews with members of a community advisory board and DIC staff to document this process, its successes, and its failures. Results: Results indicate that criminalization of drug use and stigmatization of PWUD challenged efforts to provide buprenorphine treatment in less regulated community settings. Conclusions: DIC staff and their commitment to harm reduction and advocacy facilitated the process of obtaining necessary approvals.<\/jats:p>","DOI":"10.3390\/ijerph191610382","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T22:23:13Z","timestamp":1661120593000},"page":"10382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Context in Integrating Buprenorphine into a Drop-In Center in Kampala, Uganda, Using the Consolidated Framework for Implementation Research"],"prefix":"10.3390","volume":"19","author":[{"given":"Julia","family":"Dickson-Gomez","sequence":"first","affiliation":[{"name":"Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Krechel","sequence":"additional","affiliation":[{"name":"Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Katende","sequence":"additional","affiliation":[{"name":"Uganda Harm Reduction Network, Kampala 31762, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2521-6989","authenticated-orcid":false,"given":"Bryan","family":"Johnston","sequence":"additional","affiliation":[{"name":"Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wamala","family":"Twaibu","sequence":"additional","affiliation":[{"name":"Uganda Harm Reduction Network, Kampala 31762, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Glasman","sequence":"additional","affiliation":[{"name":"Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Ogwal","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University, Kampala 7072, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geofrey","family":"Musinguzi","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University, Kampala 7072, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7517-2-12","article-title":"The Risk of Injecting Drug Use in East Africa: A Case Study from Kenya","volume":"2","author":"Beckerleg","year":"2005","journal-title":"Harm Reduct. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/10826084.2016.1264964","article-title":"Gender and Sex Trading among Active Methamphetamine Users in Cape Town, South Africa","volume":"52","author":"Lion","year":"2017","journal-title":"Subst. Use Misuse"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/hup.2228","article-title":"Substance Misuse Trends in South Africa","volume":"27","author":"Pasche","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drugpo.2015.10.006","article-title":"A Qualitative Study of Methamphetamine Initiation in Cape Town, South Africa","volume":"30","author":"Hobkirk","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13011-016-0074-1","article-title":"Using Respondent-Driven Sampling (Rds) to Recruit Illegal Poly-Substance Users in Cape Town, South Africa: Implications and Future Directios","volume":"11","author":"Burnhams","year":"2016","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dua, T., Barbui, C., Clark, N., Flieschman, A., Poznyak, V., van Ommeren, M., and Yasamy, M.T. (2011). Evidence-Based Guidelines for Mental, Neuroligical, and Substance Use Disorder in Low- and Middle-Income Countries: Summary of Who Recommendations. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001122"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(11)61385-8","article-title":"A Renewed Agenda for Global Mental Health","volume":"378","author":"Patel","year":"2011","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lancet Global Mental Health Group, Chisholm, D., Flisher, A., Lund, C., Patel, V., Saxena, S., Thornicroft, G., and Thomlinson, M. (2007). Scale up Services for Mental Disorders: A Call for Action. Lancet, 370, 1241\u20131252.","DOI":"10.1016\/S0140-6736(07)61242-2"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(07)60373-0","article-title":"Limits of Substance-Use Interventions in Developing Countries","volume":"369","author":"Obot","year":"2007","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/YCO.0b013e3282fc1ea3","article-title":"Drug and Alcohol Services in Middle-Income Countries","volume":"21","author":"Perngparn","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_11","first-page":"641","article-title":"Substance Use Problems in Developing Countries","volume":"82","author":"Uchtenhagen","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hassan, S., Cooke, A., Saleem, H., Mushi, D., Mbwambo, J., and Lambdin, B.H. (2019). Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the Re-Aim Framework. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16050728"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Nyandindi, C., Mbwambo, J., McCrudy, S., Lambdin, B.H., Copenhaver, M., and Bruce, R. (2013). Prevalence of Hiv, Hepatitis C and Depression among People Who Inject Drugs in Kinondoni Municipality in Dar Es Salaam, Tanzania, Collage on Problems of Drug Dependence.","DOI":"10.1016\/j.drugalcdep.2014.02.461"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global Prevalence of Injecting Drug Use and Sociodemographic Characteristics and Prevalence of Hiv, Hbv, and Hcv in People Who Inject Drugs: A Multistage Systematic Review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global Burden of Disease Attributable to Illicit Drug Use and Dependence: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"Lancet"},{"key":"ref_16","unstructured":"Makerere University of School of Public Health, K. Ministry of Health, Uganda, and K. Centres for Disease Control and Prevention, Uganda (Pepfar) (2017). Crane Survey Report: Bio-Behavioral Sruveys among Groups at Increased Risk for Hiv in Kampala, Uganda, Makerere School of Public Health Kampala."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12954-019-0324-4","article-title":"Hiv- and Hepatitis C-Related Risk Behaviors among People Who Inject Drugs in Uganda: Implications for Policy and Programming","volume":"16","author":"Baluku","year":"2019","journal-title":"Harm Reduct. J."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dickson-Gomez, J., Twaibu, W., Christenson, E., Katende, D., Anguzu, R., Homedi, E., and Tumwesigye, N.M. (2020). Injection and Sexual Risk among People Who Inject Drugs in Kampala, Uganda: A Qualitative Analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231969"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global Patterns of Opioid Use and Dependence: Harms to Populations, Interventions and Future Actions","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"ref_20","first-page":"234","article-title":"Canadian Trends in Opioid-Related Mortality and Disability from Opioid Use Disorder from 1990 to 2014 through the Lens of the Global Burden of Disease Study","volume":"38","author":"Orpana","year":"2018","journal-title":"Res. Policy Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2016.08.015","article-title":"Pathways through Opioid Use and offending: A Systematic Review","volume":"39","author":"Hayhurst","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11920-019-0997-0","article-title":"Global Burden of Disease and the Impact of Mental and Addictive Disorders","volume":"21","author":"Rehm","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a Risk Factor for Liver Cirrhosis: A Systematic Review and Meta-Analysis","volume":"29","author":"Rehm","year":"2010","journal-title":"Drug Alcohol Rev."},{"key":"ref_24","unstructured":"Global Commission on Drug Policy (2022, May 05). Taking Control: Pathways to Drug Policies That Work. Available online: Http:\/\/Static1.Squarespace.Com\/Static\/53ecb452e4b02047c0779e59\/T\/540da6ebe4b068678cd46df9\/14\/180843424\/Global_Commission_En.Pdf."},{"key":"ref_25","first-page":"S135","article-title":"Social Determinants and the Health of Drug Users: Socioeconomic Status, Homelessness, and Incarceration","volume":"117","author":"Galea","year":"2002","journal-title":"Public Health Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_27","first-page":"Cd002207","article-title":"Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Chochrane Database Syst. Rev."},{"key":"ref_28","unstructured":"Samhsa (2014). Medication Assisted Treatment: A Standard of Care, Samhsa."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention Stigma: How Medication-Assisted Treatment Marginalizes Patients and Providers","volume":"232","author":"Madden","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"ref_30","first-page":"11782218221103859","article-title":"\u201cYou\u2019re Not Supposed to Be on It Forever\u201d: Medications to Treat Opioid Use Disorder (Moud) Related Stigma amond Drug Treatment Providers and People Who Use Opioids","volume":"16","author":"Spector","year":"2022","journal-title":"Subst. Abus. Res. Treat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: A Rapid Review","volume":"35","author":"Mackey","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"108146","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A Systematic Review of Patients\u2019 and Providers\u2019 Perspectives on Medications for Treatment of Opioid Use Disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/ADM.0000000000000491","article-title":"\u201cI Didn\u2019t Want to Be on Suboxone At First...\u201d\u2014Ambivalence in Perinatal Substance Use Treatment","volume":"13","author":"Ostrach","year":"2019","journal-title":"J. Addict. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Louie, D.L., Assefa, M.T., and Mcgovern, M.P. (2019). Attitudes of Primary Care Physicians toward Prescribing Buprenorphine: A Narrative Review. Bmc Fam. Pract., 20.","DOI":"10.1186\/s12875-019-1047-z"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0091217420946240","article-title":"Facilitators and Barriers to Utilization of Medications for Opioikd Use Disorder in Primary Care in South Carolina","volume":"56","author":"Oros","year":"2021","journal-title":"Int. J. Psychiatry Med."},{"key":"ref_36","unstructured":"Icap at Columbia University (2018). First Methadone Clinic Opens in Tanzania\u2019s Lake Victoria Region, Icap at Columbia University."},{"key":"ref_37","unstructured":"Icap at Columbia University (2016). Mentoring Kenyan Public Health Practioners on Caring for People Who Inject Drugs, Icap at Columbia University."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/09540121.2017.1300634","article-title":"Integrated Opioid Substitution Therapy and Hiv Care: A Qualitative Systematic Review and Synthesis of Client and Provider Experiences","volume":"29","author":"Guise","year":"2017","journal-title":"Aids Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugpo.2013.08.004","article-title":"What Has Been Achieved in Hiv Prevention, Treatment and Care for People Who Inject Drugs 2010-2012? A Review of the Six Highest Burden Countries","volume":"25","author":"Degenhardt","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","article-title":"Hiv and Risk Environment for Injecting Drug Users: The Past, Present, and Future","volume":"376","author":"Strathdee","year":"2010","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugpo.2015.12.009","article-title":"\u201cCan\u2019t You Initiate Me Here?\u201d: Challenges to Timely Initiation on Antiretroviral Therapy among Methadone Clients in Dar Es Salaam, Tanzania","volume":"30","author":"Saleem","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugpo.2016.03.005","article-title":"Improvements in Health-Related Quality of Life among Methadone Maintenance Clients in Dar Es Salaam, Tanzania","volume":"30","author":"Ubuguyu","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13722-017-0089-6","article-title":"Convenience without Disclosure: A Formative Research Study of A Proposed Integrated Methadone and Antiretroviral Therapy Service Delivery Model in Dar Es Salaam, Tanzania","volume":"12","author":"Cooke","year":"2017","journal-title":"Addict. Sci. Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1080\/09540121.2013.766303","article-title":"\u201cDamaging What Wasn\u2019t Damaged Already\u201d: Psychological Tension and Antiretroviral Adherence among Hiv-Infected Methadone-Maintained Drug Users","volume":"25","author":"Batchelder","year":"2013","journal-title":"Aids Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/09540120410001683367","article-title":"Hiv, Std and Hepatitis Prevention among Women in Methadone Maintenance: A Qualitative and Quantitative Needs Assessment","volume":"16","author":"Morrow","year":"2004","journal-title":"Aids Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/09540121003758515","article-title":"\u201cWe Fear the Police, and the Police Fear Us\u201d: Structural and Individual Barriers and Facilitators to Hiv Medication Maintenance: A Qualitative and Quantitative Needs Assessment","volume":"22","author":"Mimiaga","year":"2010","journal-title":"Aids Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/apc.2013.0179","article-title":"Patient Perspectives of an Integrated Program of Medical Care and Substance Use Treatment","volume":"28","author":"Drainoni","year":"2014","journal-title":"Aids Patient Care Stds"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0b013e3181cc9610","article-title":"Reasons for Choosing office-Based Buprenorphine: Preference for Patient-Centered Care","volume":"4","author":"Korthius","year":"2010","journal-title":"J. Addict. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/QAI.0b013e3182097561","article-title":"Patient Perspectives on Buprenorphine\/Naloxone Treatment in the Context of Hiv Care","volume":"56","author":"Egan","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine\/Naloxone in Marginalized Populations","volume":"31","author":"Stancliff","year":"2012","journal-title":"J. Addict. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ADM.0000000000000096","article-title":"The Stepped Treatment Engagement Protocol for Homeless, Needle Exchange Heroin-Dependent Patients","volume":"9","author":"Tringale","year":"2015","journal-title":"J. Addict. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12954-017-0149-y","article-title":"Development and Evaluation of a Community-Based Buprenorphine Treatment Intervention","volume":"14","author":"Fox","year":"2017","journal-title":"Harm Reduct. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/ADM.0000000000000934","article-title":"Low-Threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes","volume":"16","author":"Jakubowski","year":"2021","journal-title":"J. Addict. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12954-022-00654-0","article-title":"Implementation of Buprenorphine Services in Nyc Syringe Services Programs: A Qualitative Process Evaluation","volume":"19","author":"Jakubowski","year":"2022","journal-title":"Harm Reduct. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","article-title":"Engaging an Unstably Housed Population with Low-Barrier Buprenorphine Treatment at a Syringe Services Program: Lessons Learned from Seattle, Washington","volume":"41","author":"Hood","year":"2019","journal-title":"Subst. Abus."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08897077.2018.1443541","article-title":"Description and Outcomes of a Burprenorphine Maintenance Treatment Program Integrated within Prevention Point Philadelphia, an Urban Syringe Exchange Program","volume":"39","author":"Bachhuber","year":"2018","journal-title":"Subst. Abus."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13011-022-00483-1","article-title":"Improvidng Equity and Access to Buprenorphine Treatment through Telemedicine at Syringe Services Programs","volume":"17","author":"Lambdin","year":"2022","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of Hiv Infection for People Who Inject Drugs: Why Individual, Structural, and Combination Approaches Are Needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1016\/S2352-3018(18)30292-3","article-title":"Elimination of Hiv Transmission through Novel and Established Prevention Strategies among People Who Inject Drugs","volume":"6","author":"Reddon","year":"2019","journal-title":"Lancet Hiv"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/COH.0b013e32835369ad","article-title":"Towards Combination Hiv Prevention for Injecting Drug Users: Addressing Adictophobia, Apathy and Inattention","volume":"7","author":"Strathdee","year":"2012","journal-title":"Curr. Opin. Hiv Aids"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13012-017-0550-7","article-title":"Using the Consolidated Framework for Implementation Research (Cfir) to Produce Actionable Findings: A Rapid-Cycle Evaluation Approach to Improving Implementation","volume":"12","author":"Keith","year":"2017","journal-title":"Implement. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1037\/a0022765","article-title":"Developing the Tools of Implementation Science in Substance Use Disorder Treatment: Applications of the Consolidated Framework for Implementation Research","volume":"25","author":"Sorensen","year":"2011","journal-title":"Psychol. Addict. Behav."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/COH.0000000000000566","article-title":"Transforming Lives and Empowering Communities: Evidence, Harm Reduction and A Holistic Approach to People Who Use Drugs","volume":"14","author":"Southwell","year":"2019","journal-title":"Curr. Opin. Hiv Aids"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugpo.2015.08.001","article-title":"The Global Fund to Fight Aids, Tuberculosis and Malaria\u2019s Investments in Harm Reduction through the Rounds-Based Funding Model","volume":"27","author":"Bridge","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40352-020-00111-9","article-title":"\u201cPick up Anything That Moves\u201d: A Qualitative Analysis of a Police Crackdown against People Who Use Drugs in Tijuana, Mexico","volume":"8","author":"Morales","year":"2020","journal-title":"Health Justice"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"102990","DOI":"10.1016\/j.drugpo.2020.102990","article-title":"\u201cWe Realiased We Needed a New Approach\u201d: Government and Law Enforcement Perspectives on the Implementation and Future of the Drug Decriminalisation Policy in Vietnam","volume":"87","author":"Luong","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"103180","DOI":"10.1016\/j.drugpo.2021.103180","article-title":"A Multi Critria Decision Analysis (Mcda) for Evaluating and Appraising Government Policy Responses to Non Medical Heroin Use","volume":"91","author":"Rolles","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugpo.2018.03.032","article-title":"The Impact of Drug Policy Liberalisationn on Willingness to Seek Help for Problem Drug Use: A Comparison of 20 Countries","volume":"56","author":"Benfer","year":"2018","journal-title":"Int. J. Drug Policy"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/16\/10382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:12:50Z","timestamp":1760141570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/16\/10382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":68,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijerph191610382"],"URL":"https:\/\/doi.org\/10.3390\/ijerph191610382","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]}}}